4.1 Midday Trading: A Good Start, April Fools' Day?

[Taoguba]

The overall market

2w billion incremental growth 3.26%

The SSE gap is one step away—meaning it won’t be filled

At the mouth of the cave—are you rubbing up and getting attention?

Don’t play games like that—just give me a clean, straightforward answer!

Profit effect

Strong repair, broad rebound

Profit effect, risk appetite—oversold is best

Themes: pharma + computing power

Loss effect

Bonding unwinds

Electric power

Theme

Old cycle

Geopolitical commodity outlook—the tempo is still bad

When the news you’re “hitting” is strong, you “sanitize” it

When the news you’re “sewing” is strong, there’s a crash

And if there really is a ceasefire later on,
then you don’t need to look at this direction.

Today is more like—shipping’s sub-sectors caught a补涨 (a lagging rebound).

Electric power

Anchor: Yuanneng Holding

Calculate: down turns to exhaustion

But at this point, capital is more willing to try a new cycle for “outer-cut” themes
than to chase the fifth round of lagging rebounds in the old cycle.

Yesterday’s lagging rebound was delayed by two Huadian stocks.

Those two Huadian should have, yesterday, honestly just walked out on the decline to exhaustion due to divergence,
make way for the fifth-round lagging rebound from lower levels.

In the end, one day completed exhaustion + repair.

They钻 into the “bonding” (tight grouping)—they’re doing a four-phase lagging rebound, and they won’t make room.

The lagging rebound from lower levels has no discernible identity.

Today there’s another first board: Xihua Technology.

Yesterday’s first board is still not even 2 boards.

Big tech

Inside this, Feidian and Hangdian are more like a market-led consensus “bonding” group.

The past two days, the optical module sector had a big drop—they didn’t drop. They held on to the group instead.

Today the sector is up—yet they’re weaker.

Falsheng’s one-man bonding group was threatened last night; it got hit with a trading halt after hitting the daily limit.

Today Yi Zhongtian surges; first-tier weights lead the sector, while second-tier names lag.

Storage

Last night US stocks surged in storage. Today Demingli’s results opened with a one-word limit up,
then funds cashed in—giving it a big face slap.

Domestic computing power—over here

Momentum stocks: Dashengda (big win)

Capacity stocks: Ourede and Meiliyun, all hit the daily limit one after another

This brings capital back in.

But good times don’t last. After that, strength gets blocked by pharma, so they’re no longer fermenting low-tier plays.

Hongjing Technology spikes up then falls back.

Can it come with another bottle this afternoon?

It depends on whether Huashengtiancheng can give a daily limit—igniting a fire at the point.

After Wanbangde hits the daily limit, Dashengda breaks the board.
That shows there’s an “enemy” relationship.

For domestic computing power today: watch rotation strength—complete a three-stage main upswing,
so the trend can end up perfect.

The old cycle is just like that—it’s not dead, but popularity starts to drain.

It hasn’t reached the “past you won’t think of anymore” level.

New-cycle trial and error

Commercial aerospace

Front-row discernibility: Shenjian Co., Ltd. and Zengsheng Technology—both are pushing through divergence resistance.

Today originally was exactly their divergence expectation.

Aerospace Development is the soul—it’s already been set as the tone.

Even if the divergence isn’t big, isn’t this situation that “we’re encountering strong repair momentum”?

If momentum were bad today, what would happen?

High-speed rail tracks, infrastructure—digging traps until it forces.

In the open auction, three one-word limit-ups all got busted.
To prevent getting stepped on, avoid the landmines—just look at this:

After Shenzhou high-speed rail goes one-word,
the open-auction quote for Jinying Heavy Industry needs to be green; if it’s green, that’s wrong.
Jinying Heavy Industry should at least open higher—so you can avoid the trap.

Pharma

Watching: the sector is rotating into the second stage.

But this second stage has form without spirit—
a standard second stage.

A true second stage should be:
a first-stage “live round” that actively turns strong,
a strong streak with a confident daily-limit board,
driving capital back in.

For pharma’s front row, the first two are Menovo and Wanbangde.

Neither of these two actively turned strong—Wanbangde is being pushed by the sector’s board.

Pharma strength only reached 10,000 (units) before the mid-tier front also got on the board.

Jianan Health fits the standard of actively leading momentum; the height is also acceptable.

But what it copied before was computing power—“the dark side of the moon.”
It can’t fully represent pharma.

This pharma move was, after the 3.24 resonance where the market turns at the turning point, where themes appeared.
So isn’t it just Wanbangde and Menovo?

So for new-cycle trial and error: for now, “pick pharma’s peaches.”

From the 3.24 node onward, if you count it, it “walked out” with continued follow-through,
and it built out the space and height that it managed to hit.

But is this truly a new cycle? It’s questionable.

First, the old cycle hasn’t completely gone down.

Second, pharma’s “temperament” doesn’t feel right.

So it formed the third force—specifically doing bonding

Meaning: don’t look at the old cycle if it dies. Also don’t look at the new cycle if it’s born.
Keep betting that for the next stretch, it will remain a chaotic period.

So there’s the football + Fujian play: Shu Hua Sports, and that’s also the 03.24 node stock.

So there’s Hongchang Technology for Zhangxue Motorcycle—
this is a benchmark versus Light Media; it’s basically “that kind of意思.”

Hangdian Shares, Falsheng, Changfei Optical Fiber.

Key stock commentary
**
Meiliyun**

**

**

Recently, “zhuang stocks drawing charts” are popular.

This “zhuang” has obsessive-compulsion about symmetry—needs symmetry.

Jianan is also a symmetric chart pattern—draw it out.

The K line of the adjustment wave is different, but if you watch every day,
it looks exactly the same:

They break below the 10-day and 20-day lines, then pull up to hit a daily limit.

Because after breaking below the 10-day line, short-term chips can’t be cut anymore.

A rebound daily limit basically has no selling pressure.

All are shrink-volume daily limits.

Of course, today’s daily limit has a bit of the “following in Ourede’s footsteps” meaning.

And the quality isn’t as good as the K from 03.18—you have to see whether computing power “returns” this afternoon.

That day, computing power strength was 15438.

Today, if it isn’t being watched and blocked by pharma, it would be fine—but now it’s only 5000+.

That day, in the morning the order queue was 1.1 billion; later in the afternoon, by the close it dropped to 600 million.

Today in the morning it was 600 million; now it’s already under 500 million.

**
Less important stock commentary**
**
Langfang Development**
**
Xinneng Taishan**

If the market divergence continues today, then actually it’s good news for them.

But if the market opens high, then it’s “one knife cut into the wind,” and you’re done—whatever.

Ourede

The computing power names here all have discernibility in their watchlists.

Actually, earlier in the day, Dashengda went up faster.

But the funds inside Dashengda are too “dirty.”

So I still look favorably on today’s market rebound—there’s a resonance with computing power.

For the after-hand, you’ll still need to choose Ourede.

Because compared with the bid/auction: Meiliyun opens higher than Ourede’s opening.

At the opening, it’s more主动 (more proactive).

At the afternoon close, look at whether the gap is filled, and whether there’s volume expansion.

Then judge again: is this place the end of this rebound wave,
or the start of a turning point?